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Naegeli-Franceschetti-Jadassohn Syndrome and Dermatopathia
Pigmentosa Reticularis: Two Allelic Ectodermal Dysplasias Caused
by Dominant Mutations in KRT14
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Hans Christian Hennies, Margarita Indelman, Dani Bercovich, Jouni Uitto, Reuven Bergman,
John A. McGrath, Gabriele Richard, and Eli Sprecher
Naegeli-Franceschetti-Jadassohn syndrome (NFJS) and dermatopathia pigmentosa reticularis (DPR) are two closely related
autosomal dominant ectodermal dysplasia syndromes that clinically share complete absence of dermatoglyphics (ﬁn-
gerprint lines), a reticulate pattern of skin hyperpigmentation, thickening of the palms and soles (palmoplantar kera-
toderma), abnormal sweating, and other subtle developmental anomalies of the teeth, hair, and skin. To decipher the
molecular basis of these disorders, we studied one family with DPR and four families with NFJS. We initially reassessed
linkage of NFJS/DPR to a previously established locus on 17q11.2-q21. Combinedmultipoint analysis generated amaximal
LOD score of 8.3 at marker D17S800 at a recombination fraction of 0. The disease interval was found to harbor 230
genes, including a large cluster of keratin genes. Heterozygous nonsense or frameshift mutations in KRT14 were found
to segregate with the disease trait in all ﬁve families. In contrast with KRT14 mutations affecting the central a-helical
rod domain of keratin 14, which are known to cause epidermolysis bullosa simplex, NFJS/DPR-associated mutations were
found in a region of the gene encoding the nonhelical head (E1/V1) domain and are predicted to result in very early
termination of translation. These data suggest that KRT14 plays an important role during ontogenesis of dermatoglyphics
and sweat glands. Among other functions, the N-terminal part of keratin molecules has been shown to confer protection
against proapoptotic signals. Ultrastructural examination of patient skin biopsy specimens provided evidence for increased
apoptotic activity in the basal cell layer where KRT14 is expressed, suggesting that apoptosis is an important mechanism
in the pathogenesis of NFJS/DPR.
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Naegeli-Franceschetti-Jadassohn syndrome (NFJS [MIM
161000]) is a rare autosomal dominant form of ectodermal
dysplasia. Among the most distinctive characteristics of
this syndrome is the complete absence of dermatoglyphics
(ﬁg. 1). Other frequently encountered clinical features in-
clude a typical reticulate hyperpigmentation of the skin
that tends to slowly disappear with age, palmoplantar ker-
atoderma, and decreased sweating (ﬁg. 1). Enamel defects,
other dental anomalies, skin blistering, and nail dystrophy
(ﬁg. 1) have been reported in some but not all patients.1,2
Dermatopathia pigmentosa peticularis (DPR [MIM
125595]) shares key features with NFJS but has been
distinguished from it by lifelong persistence of the skin
hyperpigmentation, partial alopecia, and absence of den-
tal anomalies.3 Nevertheless, both disorders have been
mapped to a common 6-cM interval on 17q11.2-q21,4,5
supporting the idea that NFJS and DPR are allelic
disorders.6
To resolve the molecular basis of NFJS and DPR, we stud-
ied ﬁve families with these disorders. Family 1 is a large
multigenerational Swiss family, which was originally de-
scribed by Naegeli in 1927 and has been followed since
then in a number of reports over the past 80 years.2,7,8
Family 2 is from the United States and was ﬁrst reported
with a diagnosis of DPR by Heimer et al.3 Family 3 is living
in the United States but originated in England, whereas
families 4 and 5 are living in the United Kingdom; patients
in these latter three families displayed typical features of
NFJS. In addition, diffuse hair loss and absence of dental
problems in some patients in family 3 were reminiscent
of DPR. Histopathological examination of skin biopsy
specimens obtained from patients of family 1 disclosed
mild hyperkeratosis of the epidermis, as well as accumu-
lation of upper dermal melanophages and Civatte bodies
in areas of hyperpigmentation (data not shown).
Biological specimens were obtained with informed and
written consent from all participants in accordance with
the Helsinki guidelines and after institutional review
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Figure 1. Clinical features of NFJS. a, Reticulate pigmentation
in the left axilla. b, Plantar keratoderma. c, Nail dystrophy. d,
Absence of ﬁngerprints in an NFJS patient (right) as compared
with normal ﬁngerprints (left).
board approval. We PCR ampliﬁed genomic DNA from
blood samples, buccal brushings,9 or saliva (Oragene [DNA
Genotek]) for polymorphic microsatellite markers encom-
passing the NFJS/DPR interval. PCR products were sepa-
rated by PAGE andwere visualized using the silver-staining
method10 or an ABI 310 sequencer system, followed by
allele sizing with Genescan 3.1 and Genotyper 2.0 soft-
ware (PE Applied Biosystems).
Thirteen members of family 3 were initially genotyped
for nine polymorphic microsatellite markers spanning the
NFJS/DPR interval previously localized between markers
D17S1851 and D17S934 in families 1 and 2.5 Multipoint
linkage score analysis of the data generated a maximal
LOD score of 2.99 at marker D17S800 for this family,
which is suggestive of linkage to the 17q11.2-q21 locus.
Two-point linkage analysis of the combined genotyping
data for families 1, 2, and 3, calculated across the NFJS/
DPR candidate region by use of the SuperLink online soft-
ware,11 generated a LOD score of 6.2 at marker D17S800
with a recombination fraction of 0; multipoint LOD-score
analysis performed with the same software package placed
the NFJS/DPR locus between markers D17S933 and
D17S934, with a maximum LOD score of 8.36 at marker
D17S800. Haplotype analysis in family 3 revealed a 14-
Mb–long haplotype shared in a heterozygous state by all
affected individuals. This region was shown to comprise
the critical interval previously identiﬁed in families 1 and
25 and therefore did not enable us to further reﬁne the
NFJS/DPR locus (ﬁg. 2a). DNA samples from one affected
member of family 4 and from a single patient from family
5 were available for genotyping. These two individuals
were found to share a common haplotype with family 3
patients between markers D17S946 and D17S2180 (ﬁg.
2a), suggesting that NFJS may be caused in these three
families by an identical founder mutation located within
a 6-Mb interval ﬂanked by these two markers.
Of the 1,266 genes identiﬁed on chromosome 17,12 230
are located within the NFJS/DPR interval. Of particular
interest is the presence within this interval of the distal
end of a large cluster of genes encoding type I keratin
molecules.13 Mutations in 20 different keratin genes have
been associated with epithelial genetic disorders, some of
which lead to clinical signs of skin blistering, pigmen-
tary changes, or hair and nail abnormalities, all of which
can feature, to some extent, in NFJS/DPR.14 In addition,
keratin-immunoreactive apoptotic bodies have been de-
scribed in the dermis of individuals withNFJS.15 According
to the NCBI MapViewer, the critical region for NFJS/DPR
harbors 12 soft-keratin genes, including KRT10, KRT14,
KRT15, KRT16, KRT17, KRT18, KRT19, KRT20, KRT23, and
KRT24. Mutations in KRT16 and KRT17 have been asso-
ciated with pachyonychia congenital (MIM 167200; MIM
167210), a dominant disorder manifesting with palmo-
plantar keratoderma, nail dystrophy, alopecia, leuko-
keratosis, pilosebaceous cysts, and acral skin blistering.16
In contrast, mutations in KRT14 and its expression part-
ner KRT5 are usually associated with dominant or reces-
sive forms of epidermolysis bullosa simplex (EBS [MIM
131900]),17 a mechanobullous disease characterized by
prominent skin blistering due to defective formation of
the cytoskeleton of basal keratinocytes in the epidermis.
Two previous studies4,5 have excluded a pathogenic role
for several keratin genes in NFJS/DPR, including KRT15,
KRT19, KRT20, and KRT24. Thus, we turned our attention
to 15 nonkeratin candidate genes of potential relevance
to epithelial differentiation (oligonucleotide sequences
and PCR conditions are available on request from the au-
thors):AP1GBP1, AP2B1, ATP6V0A1, andVPS25, encoding
proteins involved in vesicle trafﬁcking, which is of im-
portance in the pathogenesis of both pigmentary18 and
corniﬁcation19 disorders; RAMP2, PERLD1, FZD2, GJA7,
GJC1, MMP28, and PPARBP, coding for various elements
possibly involved in epithelial differentiation; NKIRAS2,
which may regulate NFkB activity, which in turn has been
shown to be involved in the pathogenesis of a number of
ectodermal dysplasia disorders20;GSDM1 andGSDML, cod-
ing for proteins homologous tomurine gasdermin3which
has been shown to play a critical role during hair follicle
and sebaceous gland development21; and STARD3, in-
volved in transport of lipids, which are required during
epidermal differentiation.22 In addition,we reexamined13
genes previously excluded4,5:DUSP14, LASP1,GRB7,RARA,
MPP2, MPP3, GRN, RABC5, BECN1, ARHN, KRT20, KRT23,
and KRT24. This was done because sequence data for these
genes have been updated and novel splicing patterns have
been identiﬁed for many of them. Pathogenic mutations,
however, were excluded from the coding sequence of each
of these 28 genes.
We then assessed keratin genes already known to be
associated with phenotypes distinct from NFJS/DPR:
KRT14, KRT16, and KRT17. The potential value of reex-
ploring these genes has been highlighted by recent data
showing that keratin mutations located at unusual sites
Figure 2. Candidate-gene analysis. a, Haplotype analysis of families 3–5, performed using polymorphic markers on chromosome 17q11.2-q21. Blackened symbols represent affected
individuals. The disease-associated haplotype found in the three families is boxed in red. b, Direct sequencing of KRT14 reveals pathogenic mutations in all affected individuals.
The left panels depict the mutant sequences; wild-type sequences are given for comparison on the right. c, Spectrum of dominant (red) and recessive (black) nonsense/frameshift
mutations in KRT14. The mutations are indicated along a schematic representation of the keratin 14 subdomains. The region harboring mutations causing NFJS/DPR, recessive EBS
(REBS), and dominant EBS (DEBS) are marked as red, purple, and green bars, respectively.
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Figure 3. Ultrastructural features of NFJS. a, Perinuclear keratin ﬁlament retraction without peripheral shell formation in suprabasal
cells. Tonoﬁlaments are normally connected to desmosomes (magniﬁcation #3,400). b, Keratin ﬁlament condensation in basal cells
(magniﬁcation#1,700). c, Amyloid bodies in the papillary dermis underneath the basement membrane (magniﬁcation#3,400). These
structures are composed of straight, nonbranching amyloid ﬁlaments (insert). d, The location of panels a–c is given along a scheme
of the epidermal layers.
can result in unexpected and clinically diverse pheno-
types.23,24 No mutations were identiﬁed in KRT16 and
KRT17 but direct sequencing of KRT14 revealed patho-
genic mutations in all patients with NFJS/DPR (ﬁg. 2b). In
family 1, we identiﬁed a single heterozygous guanosine
deletion at position 17 (17delG) of the KRT14 cDNA se-
quence (numbering starting from the initiation codon).
This mutation is predicted to result in a frameshift and to
generate a stop codon 8 aa downstream of the mutation
site, most likely resulting in nonsense-mediated mRNA
decay or in the synthesis of a 13-aa unstable peptide. In
affected individuals of family 2, we observed a heterozy-
gous CrA transversion at cDNA position 54, resulting in
the nonsense mutation C18X. Family 3 patients displayed
a heterozygous CrT transition, causing the substitution
of a stop codon for a glutamine residue at KRT14 amino
acid position 7 (Q7X). As predicted by the genotyping
data, the affected individuals of families 4 and 5 were also
found to carry this mutation. Sequence analysis of the
remainder of the KRT14 coding sequence did not reveal
any other pathogenic mutation in any of the affected in-
dividuals of families 1–5. However, several heterozygous
sequence variants were detected at known polymorphic
positions (data not shown), excluding the possibility of a
large deletion in one allele of KRT14.
To verify the causative mutations, we used two screen-
ing approaches. A 343-bp PCR fragment (for 17delG and
C18X) or a 202-bp PCR fragment (for Q7X) was ampliﬁed
using primer pair 5′-GAAAGTGCCAGACCCGCCCCC-3′
and 5′-GCTGAAGCCACCGCCATAG-3′ or primer pair 5′-
GAAAGTGCCAGACCCGCCCCC-3′ and 5′-GCCCGCCC-
CGATGCCGCCCC-3′, respectively. 17delG was veriﬁed
using denaturing high performance liquid chromatogra-
phy (dHPLC) heteroduplex analysis as reported else-
where.19 17delG was absent from a panel of 100 control
individuals. To verify the two other mutations, PCR-RFLP
assays were used. Mutations C18X and Q7X create a novel
recognition site for endonucleases DdeI and BfaI, respec-
tively, which were used for restriction-fragment analysis
to conﬁrm the segregation of these mutations with the
disease phenotype in families 2 and 3 and to exclude the
mutations from a panel of 100 healthy population-
matched control individuals.
To assess the cellular consequences of the identiﬁed
KRT14 mutations, we performed ultrastructural analysis
of skin biopsy specimens obtained from affected individ-
uals in family 1. Basal epidermal cells displayed condensed
keratin ﬁlaments (ﬁg. 3b), which is characteristic of ab-
errant keratin ﬁlament assembly25 and has been observed
during the early stages of apoptosis.26 In addition, perin-
uclear keratin ﬁlament retraction was seen in suprabasal
cells (ﬁg. 3a). Of note, at the periphery of the suprabasal
cells, keratin ﬁlaments were normally arranged in elon-
gated bundles and were shown to be attached to inner
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desmosomal plaques. Themost prominent ﬁndingwas the
conspicuous presence of colloid (apoptotic) bodies and
amyloid bodies (ﬁg. 3c), as well as melanophages, in the
papillary dermis.
The present ultrastructural and molecular data indicate
that NFJS and DPR are keratin disorders and should be
considered a single disorder. All keratin isoforms share a
common structure consisting of a central a-helical core
ﬂanked by two nonhelical domains of variable sequence,
termed the E1/V1 (head) and the V2/E2 (tail) domains.25
Keratin intermediate ﬁlament assembly starts with the for-
mation of keratin heterodimers always involving two des-
ignated partners, an acidic (type I) and a basic (type II)
keratin molecule. In epidermal basal cells, KRT14 pairs
with KRT5 to form the keratin cytoskeleton, which not
only provides these cells with the ability to resist me-
chanical stress but also confers to them protection against
proapoptotic signals.27 The initial and terminal sequences
of the central rod segment are extremely well conserved
over evolution and play an important role during keratin
intermediate ﬁlament assembly.25 In contrast, the variable
V2 domain seems to be required for proper keratin ﬁla-
ment supramolecular organization,23 whereas the V1 do-
main is most probably involved in interactions between
intermediate ﬁlaments and desmosomal proteins.28
Missense mutations affecting the helix initiation and
termination motifs of KRT5 or KRT14 cause EBS, which is
characterized by the occurrence of intraepidermal blis-
tering triggered by exposure of the skin to friction or
trauma.17,25 Missense mutations within these conserved
sites exert a dominant negative effect, leading to keratin
clumping in basal cells, vacuolar degeneration, and cy-
toskeleton collapse on exposure to mechanical stress,
which in turn causes cell cytolysis and intraepidermal blis-
ter formation. In contrast, mutations affecting the V1 and
V2 domain of keratins 1 and 5 have been shown to result
in unusual skin scaling/hyperkeratosis phenotypes and
thus reveal distinct roles for these particular keratin
subdomains.23,24,29,30
In the present study, pathogenic mutations, uniquely
located within the KRT14 E1/V1-encoding region, were
identiﬁed in ﬁve families affected with NFJS/DPR. All mu-
tations are predicted to generate premature termination
codons (PTC) in the immediate vicinity of the KRT14
translation initiation site. Similarly, heterozygous non-
sense mutations located in a corresponding regionofKRT5
were recently found in the autosomal dominant skin dis-
order Dowling-Degos disease (MIM 179850), which is
characterized by reticulate hyperpigmentation and small,
hyperkeratotic, dark brown papules, involving ﬂexural
skin.24 In addition, a recurrent missense mutation, P25L,
affecting the V1 domain of KRT5 has been identiﬁed in
many unrelated patients with a rare EB subtype, epider-
molysis bullosa simplex with mottled pigmentation (MIM
131960)31; recently, a heterozygous missense mutation in
KRT14 was described in a young patient with the same
disease.32 Combined with our current data, these obser-
vations provide convincing evidence that mutations in
basal keratin genes can cause both blistering and pigmen-
tary disorders of the skin.
Intriguingly, biallelic nonsense mutations in KRT14
have been shown, in rare cases, to underlie autosomal
recessive epidermolysis bullosa simplex (MIM 601001),33
although no clinical abnormalities have been reported in
the heterozygous carriers of these mutations. We therefore
reexamined six heterozygous carriers of previously pub-
lished recessive nonsense mutations in KRT14 (Q396X
and W305X) and found that none displayed either ab-
normal pigmentation or any other skin abnormalities (un-
published data). The strikingly different phenotypic man-
ifestations of recessive (EBS-causing) versus dominant
(NFJS/DPR-causing) premature truncation mutations in
KRT14 is puzzling and remains to be investigated. A pos-
sible explanation for these apparently discordant data
could be provided by the different positions of the two
types of mutations along the keratin molecule in NFJS/
DPR versus EBS. Indeed, the dominant mutations iden-
tiﬁed in the subjects in this study with NFJS/DPR are con-
ﬁned to the initial 18 aa of the KRT14 molecule, whereas
recessive EBS-causing mutations affect more-central or
-distal regions of the protein (ﬁg. 2c). NFJS-associated mu-
tant KRT14 mRNA, in contrast with recessive EBS-asso-
ciated transcripts, may be protected from nonsense-me-
diated degradation because of reinitiation of protein
translation at a downstream alternative ATG, resulting in
an N-terminally truncated protein, which in turn may
possibly exert a dominant negative effect. Such a mech-
anism has been demonstrated in a number of recessive
disorders.34,35 It is of note that Q7X could be identiﬁed by
direct sequencing of RT-PCR products in cDNA extracted
from a skin biopsy specimen that had been obtained from
a patient of family 3 (not shown); thus, Q7X does not
induce complete nonsense-mediated mRNA decay. Alter-
natively, the dominant premature truncation mutations
in KRT14 reported in the present study could result in
signiﬁcantly shorter peptides than do recessiveKRT14mu-
tations causing EBS. A steadily growing body of evidence
indicates that acidic type I keratins (but not type II keratins
or other intermediate ﬁlament proteins) may play an an-
tiapoptotic role in keratinocytes through their interaction
with TNF receptor type 1 (TNFR1)–associated death do-
main protein (TRADD).36,37 Experiments performed using
truncated keratin molecules have shown that KRT18 is
able to bind TRADD through the A1 coiled domain but
not through the proximal E1/V1 domain.36 It is conceiv-
able that differences in the degree of keratin molecule
truncation may affect the ability of the mutant protein to
engage TRADD, which in turn may lead to an increase in
apoptotic activity. The formation of apoptotic bodies and
the presence of pigment incontinence in NFJS/DPR, as
shown in ﬁgure 3c, supports this hypothesis. Moreover,
apoptosis has also been observed in NFJS near sweat
glands,15 which express KRT14 both in glandular tissues
and in myoepithelial cells.38 Although in vitro experi-
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ments performed using a keratinocyte cell line have
suggested that common KRT14 mutations may cause
apoptosis,37 we have been unable to ﬁnd ultrastructural
evidence for this phenomenon in 18 EBS cases, including
5 REBS cases, suggesting that increased apoptosis may be
more speciﬁcally associated with NFJS.
Therefore, two of the major features of NFJS/DPR, hy-
pohidrosis and abnormal epithelial differentiation, could
be explained by the marked abnormalities in keratin ﬁl-
ament function and structure. The reason for the absence
of dermatoglyphics in NFJS/DPR is another puzzle that
remains to be solved. Dermatoglyphics develop during the
ﬁrst trimester of gestation as a consequence of prolifera-
tion of KRT14-expressing basal cells into the dermis.39 A
number of rare monogenic disorders feature adermatogly-
phia, such as dyskeratosis congenita (MIM 127550), Ka-
buki syndrome (MIM 147920), and Basan syndrome (MIM
129200). In addition, several cases of inherited isolated
absence of dermatoglyphics have been reported,40,41 for
which KRT14 represents now a plausible candidate gene.
In summary, we have identiﬁed dominant PTC muta-
tions in the E1/V1-encoding region of KRT14 in ﬁve fam-
ilies with NFJS and DPR. These ﬁndings demonstrate that
NFJS and DPR are allelic diseases, expand the spectrum of
known keratin disorders, and suggest for the ﬁrst time a
role for KRT14 during the ontogenesis of sweat glands and
dermatoglyphics.
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